Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Alaunos Therapeutics (TCRT) Asset Utilization Ratio (2016 - 2025)

Alaunos Therapeutics (TCRT) has disclosed Asset Utilization Ratio for 13 consecutive years, with 0.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio fell 2.73% year-over-year to 0.0, compared with a TTM value of 0.0 through Sep 2025, down 2.73%, and an annual FY2024 reading of 0.0, up 1228.73% over the prior year.
  • Asset Utilization Ratio was 0.0 for Q3 2025 at Alaunos Therapeutics, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.08 in Q2 2023 and bottomed at 0.0 in Q3 2023.
  • Average Asset Utilization Ratio over 5 years is 0.01, with a median of 0.0 recorded in 2021.
  • Peak annual rise in Asset Utilization Ratio hit 1406.92% in 2023, while the deepest fall reached 100.72% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.0 in 2021, then skyrocketed by 1043.43% to 0.04 in 2022, then crashed by 99.18% to 0.0 in 2023, then surged by 690.89% to 0.0 in 2024, then crashed by 50.31% to 0.0 in 2025.
  • Business Quant data shows Asset Utilization Ratio for TCRT at 0.0 in Q3 2025, 0.0 in Q2 2025, and 0.0 in Q1 2025.